Skip to content
Clinical Trials – home

Institutul Național de Gerontologie și Geriatrie​ "Ana Aslan"

Verified siteinfo

Romania Str Manastirea Caldarusani 9 Sector 1, 78178 Bucharest, Romania

  • 5 trials recruiting
  • Bipolar I disorder · Mania · Dementia Alzheimer's type
  • Adult patients

About Specializations

Institutul Național de Gerontologie și Geriatrie​ "Ana Aslan" in Bucharest, Romania specialises in clinical trials of conditions such as Bipolar I disorder, Mania, Dementia Alzheimer's type, Anxiety, and other specialisations. This site conducts important research.

Main research areas of the site

Psychiatry and Psychology at Institutul Național de Gerontologie și Geriatrie “Ana Aslan”

This site is conducting clinical research in mental disorders, with studies focused on bipolar-I disorder and mania. The work is aimed at understanding how new treatments may help manage mood symptoms more effectively and support longer-term care.

  • Evaluating a new therapy for manic episodes in bipolar-I disorder
  • Assessing the long-term safety and tolerability of treatment for mania with mixed features

The research at this Bucharest site reflects a strong interest in improving treatment options for serious psychiatric conditions that can affect daily functioning and quality of life.

Neurocognitive Disorders and Brain Health

Another major area of study at the site involves Alzheimer’s disease, especially mild to moderate Alzheimer’s disease with cognitive impairment and reduced global functioning. These trials are designed to explore whether new treatment approaches can help preserve thinking skills and overall independence.

  • Testing a potential therapy for Alzheimer’s disease and related cognitive symptoms
  • Measuring whether treatment can improve thinking skills and global functioning

This research supports efforts to better understand and treat memory and reasoning problems in older adults, aligning with the geriatric expertise of the Institutul Național de Gerontologie și Geriatrie “Ana Aslan”.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Str Manastirea Caldarusani 9 Sector 178178 BucharestRomania
Recruiting now
5 trials
Conditions studied
6
Partner status
Verified site

More sites in BucharestRomania

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

7 clinical trials

Bipolar I disorder+1

Recruiting

A study testing xanomeline tartrate and trospium chloride added to current treatment for adults with bipolar I disorder experiencing mania

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years
  • Substances:Trospium Chloride
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Study of xanomeline tartrate and trospium chloride combination for cognitive impairment in people with mild to moderate Alzheimer's disease

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Trospium Chloride
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Bipolar I disorder+1

Recruiting

Long-term safety study of trospium chloride and xanomeline tartrate combination (KarXT) for treatment of manic episodes in adults with Bipolar I Disorder

InvestigationalNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Trospium Chloride
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Bipolar I disorder+1

Recruiting

Study of trospium chloride and xanomeline tartrate (KarXT) for treating manic episodes in adults with bipolar I disorder

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years
  • Substances:Trospium Chloride
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Psychotic disorder+1

Recruiting

Study of trospium chloride and xanomeline tartrate (KarXT) in patients with psychosis associated with Alzheimer's disease

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Trospium Chloride
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Schizophrenia

Not yet recruiting

Phase 3 Double‑Blind Relapse Prevention Trial of Trospium Chloride and Xanomeline Tartrate (KarXT) in Adults with Schizophrenia

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Trospium Chloride
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Anxiety

Not yet recruiting

Efficacy of Etifoxine in Adults with Adjustment Disorder with Anxiety: A Randomized, Double‑Blind, Placebo‑Controlled Trial

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Etifoxine Hydrochloride
  • Sponsor:Biocodex
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.